Metis Global Partners’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$209K Sell
2,706
-1,561
-37% -$114K ﹤0.01% 675
2026
Q1
$279K Sell
4,267
-492
-10% -$36.5K 0.01% 651
2025
Q4
$377K Sell
4,759
-303
-6% -$23.2K 0.01% 628
2025
Q3
$370K Buy
5,062
+8
+0.2% +$586 0.01% 636
2025
Q2
$383K Sell
5,054
-662
-12% -$46.9K 0.01% 632
2025
Q1
$435K Buy
5,716
+988
+21% +$73.6K 0.01% 613
2024
Q4
$312K Buy
4,728
+280
+6% +$19.6K 0.01% 657
2024
Q3
$310K Sell
4,448
-42
-0.9% -$2.53K 0.01% 662
2024
Q2
$237K Buy
+4,490
New +$273K 0.01% 691

Other funds holding SOLV

Metis Global Partners's SOLV Position: Q2 2026 in Review

Metis Global Partners reduced its Solventum (SOLV) stake by 37% in Q2 2026, selling an estimated $114K and leaving 2,706 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #675.

Metis Global Partners first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $435K in Q1 2025. 875 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Metis Global Partners held 2,706 shares of Solventum worth $209K as of Q2 2026.
  • Metis Global Partners sold 1,561 Solventum shares in Q2 2026, an estimated $114K.
  • Solventum made up ﹤0.01% of Metis Global Partners's portfolio in Q2 2026, its #675 holding.
  • Metis Global Partners first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Metis Global Partners's Solventum position peaked at $435K in Q1 2025.
  • 875 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.